Skip to content
healthcare.dev
Get a free key

Kimyrsa

NDC 70842-225, oritavancin diphosphate, injection, powder, lyophilized, for solution, from Melinta Therapeutics, LLC.

Product NDC
70842-225
Status
Listed
Labeler
Melinta Therapeutics, LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA214155
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70842-225 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ORITAVANCIN DIPHOSPHATE1200 mg/40mL

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 2D6 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Lipoglycopeptide Antibacterial [EPC]; Lipoglycopeptides [CS]

Package NDCNDC-11Package
70842-225-01708420225011 VIAL in 1 CARTON (70842-225-01) / 40 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5e755c40-6e73-4572-b474-4d8a131693d1

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70842-225

Use it

Look up 70842-225 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70842-225 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70842-225. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.